BIODESIX, INC. (BDSX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $11.00K; Additional Paid in CapitalUSD $521.96M; Retained Earnings (Accumulated Deficit)USD $-512.83M; Stockholders' Equity Attributable to ParentUSD $9.14M.
- 2026-03-31: Common Stock, Value, IssuedUSD $10.00K; Additional Paid in CapitalUSD $514.68M; Retained Earnings (Accumulated Deficit)USD $-505.56M; Stockholders' Equity Attributable to ParentUSD $9.13M.
- 2025-12-31: Common Stock, Value, IssuedUSD $8.00K; Additional Paid in CapitalUSD $495.29M; Retained Earnings (Accumulated Deficit)USD $-497.76M; Stockholders' Equity Attributable to ParentUSD $-2.46M.
- 2025-09-30: Common Stock, Value, IssuedUSD $8.00K; Additional Paid in CapitalUSD $492.05M; Retained Earnings (Accumulated Deficit)USD $-493.78M; Stockholders' Equity Attributable to ParentUSD $-1.72M.
BIODESIX, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.00K | $521.96M | $-512.83M | $9.14M | 3 month · $820.00K | (m) | (m) |
| 2026-03-31 | $10.00K | $514.68M | $-505.56M | $9.13M | 3 month · $1.11M | 3 month · $1.25M | (m) |
| 2025-12-31 | $8.00K | $495.29M | $-497.76M | $-2.46M | 12 month · $4.14M | 12 month · $280.00K | (m) |
| 2025-09-30 | $8.00K | $492.05M | $-493.78M | $-1.72M | 3 month · $1.05M | 9 month · $280.00K | (m) |
| 2025-06-30 | $146.00K | $486.06M | $-485.07M | $1.14M | 3 month · $1.04M | 3 month · $280.00K 6 month · $280.00K | (m) |
| 2025-03-31 | $146.00K | $484.51M | $-473.60M | $11.06M | 3 month · $972.00K | (m) | (m) |
| 2024-12-31 | $7.00K | $483.37M | $-462.50M | $20.88M | 12 month · $6.64M | (m) | (m) |
| 2024-09-30 | $145.00K | $481.96M | $-454.25M | $27.86M | 3 month · $1.51M | (m) | (m) |
| 2024-06-30 | $145.00K | $480.10M | $-443.99M | $36.26M | 3 month · $1.22M | (m) | (m) |
| 2024-03-31 | $97.00K | $427.58M | $-433.18M | $-5.50M | 3 month · $2.64M | (m) | (m) |
| 2023-12-31 | $96.00K | $424.05M | $-419.57M | $4.58M | 12 month · $5.37M | (m) | (m) |
| 2023-09-30 | $88.00K | $408.89M | $-410.43M | $-1.45M | 3 month · $954.00K | (m) | (m) |
| 2023-06-30 | $79.00K | $392.41M | $-399.48M | $-6.99M | 3 month · $1.06M | 3 month · $674.00K | (m) |
| 2023-03-31 | $78.00K | $390.59M | $-386.12M | $4.55M | 3 month · $2.28M | (m) | (m) |
| 2022-12-31 | $78.00K | $387.95M | $-367.42M | $20.61M | 12 month · $5.96M | 12 month · $2.91M | (m) |
| 2022-09-30 | $41.00K | $344.14M | $-347.08M | $-2.90M | 3 month · $1.17M | (m) | (m) |
| 2022-06-30 | $40.00K | $341.01M | $-333.38M | $7.67M | 3 month · $1.37M | (m) | (m) |
| 2022-03-31 | $32.00K | $325.31M | $-317.56M | $7.78M | 3 month · $1.35M | (m) | (m) |
| 2021-12-31 | $31.00K | $321.67M | $-301.97M | $19.73M | 12 month · $4.94M | (m) | (m) |
| 2021-09-30 | $27.00K | $304.70M | $-288.69M | $16.03M | 3 month · $1.39M | (m) | (m) |
| 2021-06-30 | $27.00K | $302.92M | $-277.18M | $25.77M | 3 month · $539.00K 6 month · $539.00K | (m) | (m) |
| 2021-03-31 | $27.00K | $302.18M | $-265.77M | $36.43M | 3 month · $1.75M | (m) | (m) |
| 2020-12-31 | $27.00K | $299.95M | $-258.81M | $41.17M | 12 month · $3.71M | 12 month · $8.27M | 12 month · $26.62M |
| 2020-09-30 | $2.00K | $2.50M | $-257.68M | $-251.78M | 3 month · $100.00K | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | $-243.04M | 3 month · $55.00K | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | $-234.83M | (m) | (m) | (m) |
| 2019-12-31 | $1.00K | $2.32M | $-227.46M | $-225.14M | 12 month · $170.00K | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | $-222.06M | 3 month · $45.00K | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | $-212.52M | 3 month · $49.00K | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | $-205.71M | 3 month · $31.00K | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | $-194.63M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |